Endo’s Opana IR Should Not Add Pediatric Data To Labeling, US FDA Panel Says

 
• By Sue Sutter
  
FDA Advisory Committee Feature image
An AdComm voted against approval of pediatric labeling for Opana IR.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers